238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.09%
Positive revenue growth while BIDU is negative. John Neff might see a notable competitive edge here.
12.01%
Positive gross profit growth while BIDU is negative. John Neff would see a clear operational edge over the competitor.
15.12%
Positive EBIT growth while BIDU is negative. John Neff might see a substantial edge in operational management.
15.12%
Positive operating income growth while BIDU is negative. John Neff might view this as a competitive edge in operations.
5.37%
Net income growth under 50% of BIDU's 33.12%. Michael Burry would suspect the firm is falling well behind a key competitor.
5.41%
EPS growth under 50% of BIDU's 33.64%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
5.56%
Diluted EPS growth under 50% of BIDU's 33.96%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.33%
Share count expansion well above BIDU's 0.10%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.25%
Diluted share count expanding well above BIDU's 0.15%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-4.39%
Negative OCF growth while BIDU is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-13.11%
Negative FCF growth while BIDU is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
610.45%
10Y revenue/share CAGR under 50% of BIDU's 6408.06%. Michael Burry would suspect a lasting competitive disadvantage.
131.47%
5Y revenue/share CAGR under 50% of BIDU's 309.35%. Michael Burry would suspect a significant competitive gap or product weakness.
50.07%
3Y revenue/share CAGR at 50-75% of BIDU's 92.91%. Martin Whitman would question if the firm lags behind competitor innovations.
803.01%
Positive long-term OCF/share growth while BIDU is negative. John Neff would see a structural advantage in sustained cash generation.
125.45%
Positive OCF/share growth while BIDU is negative. John Neff might see a comparative advantage in operational cash viability.
74.43%
3Y OCF/share CAGR of 74.43% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
352.08%
Below 50% of BIDU's 3037.19%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
85.36%
5Y net income/share CAGR at 75-90% of BIDU's 102.20%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
53.33%
3Y net income/share CAGR similar to BIDU's 49.59%. Walter Schloss would attribute it to shared growth factors or demand patterns.
612.93%
Below 50% of BIDU's 6461.25%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
124.74%
Below 50% of BIDU's 506.81%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
54.57%
Below 50% of BIDU's 142.22%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
14.82%
AR growth well above BIDU's 7.34%. Michael Burry fears inflated revenue or higher default risk in the near future.
-52.06%
Inventory is declining while BIDU stands at 103.95%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
4.72%
Asset growth well under 50% of BIDU's 10.33%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.34%
50-75% of BIDU's 4.59%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-0.08%
We’re deleveraging while BIDU stands at 11.49%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
0.72%
R&D dropping or stable vs. BIDU's 13.70%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
17.16%
We expand SG&A while BIDU cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.